Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis

BACKGROUND: Deficits in the mismatch negativity (MMN) and P3a components are the most reliable and robust findings in schizophrenia. These abnormalities have also been recently documented in individuals clinically at risk for psychosis, indicating that the MMN may be a potential biomarker for psycho...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Jennifer R, Rawdon, Caroline, Kelleher, Ian, Twomey, Deirdre, Markey, Patrick S, Cannon, Mary, Roche, Richard AP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598448/
https://www.ncbi.nlm.nih.gov/pubmed/23375130
http://dx.doi.org/10.1186/1471-244X-13-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598448/
https://www.ncbi.nlm.nih.gov/pubmed/23375130
http://dx.doi.org/10.1186/1471-244X-13-45

Ejemplares similares